
Roland Magnusson/iStock Editorial via Getty Images
AstraZeneca (NASDAQ:AZN) ADRs added ~2% in the morning hours on Tuesday after The Times reported that CEO Sir Pascal Soriot has privately indicated his willingness to shift the company’s stock listing to the U.S. from the U.K.
Citing people familiar